Clin2
NCT05995418Likely a fitRecruiting

Cost and health impact study for Alzheimer's in China

Alzheimer Disease

Part of Brain & nervous system, Mental health clinical trials.

This study looks at the financial and health effects of Alzheimer's disease and mild cognitive impairment (aMCI) in China. It aims to understand how the disease affects patients and families over time.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
9,510 people
Ages
40 years to 100 years
Study type
Observational

Who can take part

  • You have been diagnosed with aMCI or Alzheimer's disease (based on standard criteria).
  • Your Clinical Dementia Rating (a measure of dementia severity) is 0.5 or higher.
  • You can see, hear, and speak well enough to complete thinking and memory tests (or can do them with help like glasses or hearing aids).
  • You or your legal guardian agree to take part and sign a consent form.
  • You do not have a history of stroke with certain brain changes seen on scans.
  • You do not have other conditions that could cause memory loss (like developmental delay or mental illness).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07109999Recruiting
Biomarker study for Alzheimer's disease

This study uses brain scans or spinal fluid tests to confirm Alzheimer's-related changes. It aims to track the disease over time to better understand and improve care.

Beijing, Beijing Municipality
NCT07571161Recruiting· Phase 3
Donanemab for early Alzheimer's disease in Chinese participants

This trial tests a drug called donanemab in people who have early signs of Alzheimer's disease (amyloid buildup in the brain) but are still thinking clearly. The goal is to see if the drug can slow or prevent cognitive decline before memory problems start.

Beijing
NCT06827678Recruiting
Study of Alzheimer’s disease using brain scans in China

This study uses brain imaging to understand early changes in Alzheimer's disease. It may help people with or without memory problems learn more about their condition and support future treatments.

Shanghai
NCT05597410Recruiting
Study of people at risk for Alzheimer’s in Shanghai

This study follows people who are closely related to someone diagnosed with Alzheimer’s to see who develops memory or brain changes over time. It may help researchers understand risk and early signs, which could guide prevention in families like yours.

Shanghai, Shanghai Municipality
NCT07286812Not yet recruiting
Screening for early memory issues in community adults

This study uses digital tools and blood tests to check for early signs of memory problems in healthy older adults living in the community. The goal is to find people who might be at risk for conditions like Alzheimer's disease before symptoms get worse.

Shenyang, Liaoning
NCT03810794Recruiting
Acupuncture study for people with Alzheimer’s memory problems

This trial tests whether acupuncture can improve symptoms in people with Alzheimer’s disease. You may qualify if you have memory and thinking changes consistent with Alzheimer’s and meet imaging and brain-scan score requirements.

Shanghai, Shanghai Municipality

Hear when a new Alzheimer Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.